168 related articles for article (PubMed ID: 12610865)
1. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan].
Kagawa S; Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
[TBL] [Abstract][Full Text] [Related]
4. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M
Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456
[TBL] [Abstract][Full Text] [Related]
5. [Adenoviral p53 gene therapy for human lung cancer].
Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
[TBL] [Abstract][Full Text] [Related]
6. [A phase I trial of adenoviral p53 gene therapy for non-small cell lung cancer].
Fujiwara T; Kataoka M; Kawamata O; Tanaka N
Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):749-55. PubMed ID: 10629843
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy for lung cancer].
Kataoka M; Fujiwara T; Tanaka N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):244-9. PubMed ID: 11904988
[TBL] [Abstract][Full Text] [Related]
8. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
9. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B
Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844
[TBL] [Abstract][Full Text] [Related]
10. Viral and non-viral vectors for cancer gene therapy.
Cristiano RJ
Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p53 in non-small-cell lung cancer.
Komiya T; Hirashima T; Kawase I
Oncol Rep; 1999; 6(1):19-28. PubMed ID: 9864395
[TBL] [Abstract][Full Text] [Related]
12. Current status of gene therapy for lung cancer and head and neck cancer.
Moon C; Oh Y; Roth JA
Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
14. Restoration of tumour suppressor gene expression for cancer.
Roth JA
Forum (Genova); 1998; 8(4):368-76. PubMed ID: 9863031
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced non-small lung cancer responding to tumor suppressor p53 gene therapy].
Kagawa S; Ohtani S; Tanaka N; Fujiwara T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1788-90. PubMed ID: 15553716
[TBL] [Abstract][Full Text] [Related]
16. New horizons: gene therapy for cancer.
Baselga J
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S39-42. PubMed ID: 10630368
[TBL] [Abstract][Full Text] [Related]
17. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
Kandioler D; Stamatis G; Eberhardt W; Kappel S; Zöchbauer-Müller S; Kührer I; Mittlböck M; Zwrtek R; Aigner C; Bichler C; Tichy V; Hudec M; Bachleitner T; End A; Müller MR; Roth E; Klepetko W
J Thorac Cardiovasc Surg; 2008 May; 135(5):1036-41. PubMed ID: 18455581
[TBL] [Abstract][Full Text] [Related]
18. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer].
Fujiwara T; Inoue F; Tanaka N
Gan To Kagaku Ryoho; 1998 Jan; 25(2):194-200. PubMed ID: 9474928
[TBL] [Abstract][Full Text] [Related]
19. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
Huang CL; Yokomise H; Miyatake A
Future Oncol; 2007 Feb; 3(1):83-93. PubMed ID: 17280505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]